Leading European vaccine products by market share 2015-2022
This statistic displays a projection of the top 3 European vaccine products and their respective market share worldwide in 2015 and 2022. Sanofi's influenza vaccine, Fluzone, is expected to accumulate 5.2 percent of the global market based on revenues by 2022. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.
